VNRX – volitionrx limited (US:NASDAQ)

News

VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants [Yahoo! Finance]
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
VolitionRx Limited (NYSE: VNRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com